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Introduction
The ﬁrst phase of wound healing, namely the inﬂammatory
phase, involves three major components for healing: inﬂam-
matory cells, inﬂammatory mediators and thrombocytes.1,2
The process is quite similar between species,2 but differences
in healing capacity have been described for different species
including dogs and cats, as well as horse and ponies.3–6 The
current knowledge of physiological and delayed wound heal-
ing indogshasmainlybeen transferred fromfactsgenerated in
humans,7 with a lack of species-speciﬁc pathophysiological
studies of healing. Studies in humans and pigs have suggested
that negative pressure wound therapy (NPWT) exerts pro-
found effects on thewound including cytokine—andevengene
modiﬁcation.8,9 The systemic effect of this therapy is still
under debatewith a very few studies investigating this aspect.
A study of diabetic ulcers in man found no effect on systemic
leucocytes with a beneﬁcial effect on C-reactive protein (CrP)
development under therapy.10 Interestingly, clinical trials in
dogs and cats suggest that there might be an impact on
systemic infection, especially development of systemic signs
of systemic inﬂammatory response syndrome and sepsis in
patients treated with NPWT. Nolff and colleagues retrospec-
tively detected improved infection control and fewer cases
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Abstract Objectives The aim of this study was to evaluate the systemic effect of negative
pressure wound therapy (NPWT) on the treatment of complicated wounds in dogs.
Materials and Methods Dogs undergoing open wound treatment were randomly
assigned to one of two groups: NPWT (n ¼ 11) or polyurethane foam dressing
(n ¼ 11). Rectal temperature, heart rate as well as haematocrit, thrombocytes, leucocyte
count, band neutrophils, C-reactive protein (CrP), total protein and albumin were recorded
daily from the beginning of therapy (day 0) until day 5, as well as on day 10. The effect of
treatment on systemic parameters was evaluated as well as the prognostic power of the
individual parameters with regard to successful wound closure.
Results A more profound systemic decrease was found in total protein under NPWT.
This difference was non-signiﬁcant. Patients with non-successful closure displayed a
non-signiﬁcant trend towards lower initial leukocyte and thrombocyte counts and
signiﬁcantly higher CrP values on days 4, 5 and 10 (p < 0.05) compared with
successfully treated patients. Receiver operating characteristic analysis revealed an
optimal cutoff value of 70.2 mg/L at day 4 (sensitivity 80; speciﬁcity of 85.7).
Conclusion Theremight be an increased loss of protein in NPWT-treated patients, which
doesnot affect albumin levels, otherwiseno systemiceffectsweredetectedcomparedwith
the control treatment. The parameter with the best sensitivity and speciﬁcity to detect
serious complications (no wound closure achieved) was CrP at day 4.
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with progressing signs of sepsis under NPWT compared with
polyurethane foam treatment in dogs and cats.11,12 But so far,
there are no prospective randomized studies available to
underline and quantify this effect. It is generally accepted
that awound is a local problem that shouldhave little systemic
impact,1 which might be one of the reasons why systemic
impacts of treatment are not frequently investigated. How-
ever, previous studies demonstrated that one of the main
reasons for open wound treatment in dogs and cats is
uncontrollable infection frequently linkedwith systemic signs
of sepsis.11,12 Incontrast tochronicwoundsofotherorigin, this
subtype of wounds represents a group in which systemic
effects frequently complicate the situation. Failure to control
local and systemic infection are the main reasons for unsuc-
cessful treatment of these patients.11,12
Wound infection—especially early stages—is not always
easily differentiated from normal healing. The presence of
bacteria alone is not helpful, since the bacterial bioburden
can be presentwithoutmajor harmof the patient.13 Therefore,
it seems reasonable to investigate if there are systemic factors,
measurable inaclinical examinationor inastandardblood test,
whichmight be inﬂuenced by treatment—and furthermore—if
any of those actually qualify as prognostic factors to identify
ongoing infection and potentially predict unsuccessful treat-
ment. This is whywe decided to restrict our focus for systemic
inﬂammation on the following parameters. The aim of this
study was to evaluate the effect of NPWT on several systemic
parameters and to compare it to a foam dressing treatment
protocol to identify differences. Furthermore, the prognostic
value of rectal temperature, heart rate, leucocyte count, band
neutrophil count, haematocrit, thrombocyte count, total pro-
tein, albumin and CrP on day 0–5 and 10 was evaluated. The
hypothesis was that NPWTwould positively inﬂuence several
systemic parameters such as signs of infection. Furthermore,
we suggested that prolonged signs of infection such as pro-
gressive leucocytosis, CrP increase, an increase in temperature
or heart rate would be related to unsuccessful wound closure
after open wound treatment and if one or more of these
parameters could be employed as a prognostic factor for a
successful wound healing.
Materials and Methods
The study was performed between July 2014 and September
2016 after approval of the ethic commission of the faculty
(22–27–02–2014). Dogs were included if they were presented
with injuries requiring openwound treatment due to traumatic
tissue loss or infection if previous attempts of closurehad failed.
Patients were assigned to one of two treatment groups using
randomnumerical lists generated by Excel (Microsoft Corpora-
tion; Redmond, Washington, United States) (►Supplementary
Appendix Table 1, available in online version only).
Treatment Protocols
After owner consent, the patients underwent a general clinical
examination, and further diagnostic steps if necessary. A
haematology, serum chemistry proﬁle as well as CrP were
obtained from all patients before initiation of therapy. All
wounds were then debrided and lavaged, while the patient
was under general anaesthesia using polyhexanide biguanide
(Prontovet;B. Braun,Melsungen, Germany). InGroupA,NPWT
was performed at a continuous pressure of –125 mm Hg
(V.A.C. GranuFoam; TracPad; ActiVAC, KCI, Wiesbaden,
Germany). InGroupB, thewoundswere initially coveredusing
a foil-coated foam dressing (ALLEYVIN Cavity; Smith &
NephewGmbH,Hamburg, Germany) sutured to the surround-
ing skin and changed as needed. Once wound exudation had
decreased to a level which allowed the dressings to be left in
place for more than 24 hours, the dressing was changed to
silver-coated foam (Acticoat Moisture Control; Smith &
Nephew GmbH). Planned dressing changes were performed
every 3 days during the ﬁrst 9 days, and every 2 to 3 days
thereafter in both groups. All patients received treatmentwith
amoxicillin/clavulanic acid at a dose of 12.5mg/kg three times
a day (intravenously as long as venous catheters were present,
followed by oral administration). Antibiotic treatment was
adjusted based on the results of microbiological culture if
needed. Analgesia was performed based on the degree of the
injury either using fentanyl-ketamine-lidocaine constant rate
infusion for 3 days followed by transdermal fentanyl or a pure
fentanyl constant rate infusion for 12 hours, followed by
transdermal fentanyl. In cases where prolonged analgesia
was needed, this was achieved by administering tramadol
orally (5 mg/kg three times a day). No non-steroidal drugs or
cortisone were permitted in any patient during treatment.
Additional treatment was performed as needed based on the
severity of the condition of the patients.
Special Investigated Parameters
The following parameterswere assessed at day 0 to 5 aswell as
day 10: rectal body temperature (°C), heart rate (BPM), leuco-
cyte count (109/L), band neutrophil count (109/L), CrP (mg/L),
haematocrit (%), thrombocyte count (109/L), total protein (g/L)
as well as albumin (g/L). Complications were deﬁned as severe
local deterioration of the wound, increased exudation,
increased infectionornecrosisofsurroundingareasor systemic
infections precluding closure under therapy. If successful man-
agement of the wounds was not achieved under the rando-
mized treatment option, treatment was changed to the most
successful potential alternative (foam!NPWT, NPWT!NPWT
with instillationof a solution,NPWT ! amputation in case of a
limb injury) and patients were classiﬁed as ‘unsuccessful
closure achieved under therapy’. Wounds were considered
successfully treated if complete closure was achieved and no
complications necessitating further surgical treatment devel-
oped within 6 weeks after closure.
Statistical Analysis
Statistical analysis was performed using G-power 3.1
(G-Power 3.1; Heinrich Heine University, Düsseldorf,
Germany), BIAS forwindows 11 (BIAS forwindows 11;Goethe
University, Frankfurt, Germany), SPSS (SPSS 20.0; IBM,
Munich, Germany) and MedCalc (MedCalc Software; Ostend,
Belgium).Effect size (Cohen’s-d) andpowerwerecalculated for
all parameters with regard to treatment (NPWTvs. foam) and
wound closure (closure vs. non-closure). Parameters with an
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appropriate power (>0.8) were tested for normality using
Shapiro–Wilk test. Signiﬁcance was set at p < 0.05 and eval-
uated using t-test for independent means in normally distrib-
uted data. Non-normally distributed data were tested using
the Mann–Whitney U test. Finally, cutoff values were deter-
mined using receiver operating characteristic analysis for
parameters that reached signiﬁcance (►Fig. 1).
Results
A total of 21 dogs with 22 wounds located at the different
body areas including the trunk as well as the extremities
were enrolled within the study. One dog developed two
separate wounds at different time points and was thus
included twice, resulting in a total of 11 wounds included
per group. There were no signiﬁcant differences between
groups regarding the mean age (NPWT: 69 months [range:
8–160 months], foam: 92 months [range: 54–152 months]),
weight (NPWT: 40.6 kg [range: 5.5–93 kg], foam 40.8 kg
[range: 10.8–93 kg]) or wound localization. The majority
of patients showed signs of local infection on initial wound
evaluation (NPWT 9/11, foam 8/11) and nine patients per
group had positive initial bacterial cultures. Further details
regarding the patients and wound types can be found
in ►Supplementary Appendix Table 1 (available in online
version only).
Fig. 1 Receiver operating characteristic analysis illustrating sensitivity and speciﬁcity of C-reactive protein (CrP) on day 0 (A), day 1 (B), day 2 (C), day 3 (D),
day 4 (E), day 5 (F) and day 10 (G) with respect to closure. CrP at day 4 yielded the most reliable combined sensitivity and speciﬁcity.
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Comparison of Systemic Parameters within Treatment
Groups
None of the parameters tested showed signiﬁcant differences
within the treatment groups. Patients in both groups initially
showed mild leucocytosis and mildly increased band neu-
trophil counts, especially at days 1 and 2 after surgery, which
normalized during the course of treatment in both groups. In
contrast to leucocytes, mean CrP increase was profound,
with a peak after the initial debridement and slow decrease
during the time of the study; however, in contrast to leuco-
cytes, mean CrP did not reach normal values during the
course of observation. Total protein already showed a mini-
mal decrease in the NPWT group at day 0, and further
decreased mildly in both groups during the observation
period. Mean total protein as well as albumin on day 0 was
within normal limits with a slow decrease in both groups
with a nadir at day 5 followed by an increase at day 10.
Interestingly, total protein was the parameter with the
largest detected treatment associated effect (Cohen’s-d
between 0.6 and 1) at all days, while no effect of treatment
(Cohen’s-d 0–0.2) was detectable regarding albumin devel-
opment throughout thewhole time. Due to the relative small
detected effects, none of the tested parameters reached a
sufﬁcient power (>0.8) for further testing. However, within
the group of tested parameters, the largest effects of therapy
were detected for total protein.
Comparison of Systemic Parameters With Regard to
Closure
Wound closure under initial therapy was achieved in 16/22
wounds. Six out of twenty wounds developed serious compli-
cations precluding closure under the chosen regimen. Within
the wounds treated with NPWT, one dog developed severe
thromboembolism of the entire vasculature of the lower limb
and paw, resulting in necrosis as conﬁrmed by histopathology.
Therapy was discontinued at day 13 and the limb was ampu-
tated. The secondpatient had a severe soft tissue infection and
osteomyelitis of the distal phalanx bone of the fourth left hind
digit. The dog removed the dressing and caused severe auto-
mutilation during therapy; therefore, high amputation of the
toe followed at day 32. The wound ﬁnally healed, but the dog
developed septic myocarditis and died.
Withinwounds treatedwith a foam dressing, therapy had
to be discontinued due to progressive wound infection at
day 4 in one patient, as well as due to severe ongoing
panniculitis and systemic sepsis in two more patients at
days 7 and 10. In the fourth patient, large volumes of wound
discharge necessitatedmultiple dressing changes per day. As
wound excretion did not decline by day 10 and no real
granulation occurred, this patient was removed from the
study and transitioned to NPWT treatment, resulting in
decline of discharge and smooth granulation of the wound.
One patient in each group died due to wound-related causes
(severe infection), while in both groups one patient that was
successfully treated died due to unrelated reasons (intra-
abdominal haemorrhage and end-stage cardiac disease) at 3
and 6 months after wound closure.
The majority of patients showed signs of local infection
(17/23) andpositivebacterial culture, on initialwoundevalua-
tion with no signiﬁcant differences detected between groups.
Mean leucocyte counts were increased at day 0 and 1 in
patients in which closure was successful, while they stayed
within normal limits in patients where no closure was
achieved. Bandneutrophils also tended tobehigher inpatients
with successful closure, indicating a more profound immune
reaction.However, neither the leucocyte count atday 1nor the
band neutrophil count at days 1 and 2 was signiﬁcant (power
> 0.85). In contrast to this, an initial increase in CrP was
evident in both groups; however, while patients in which no
closure was achieved started with a lower CrP comparedwith
‘closed’ patients, values after debridement at day 0 became
comparable, with a trend of constant decrease in patientswith
successful closure, with slower decrease or even increase in
non-closed patients (►Fig. 2). The difference in CrP levels in
patientswithnoclosurewasachievedwassigniﬁcant forday4,
5 and10 (p < 0.05). Thehighest sensitivity (80) and speciﬁcity
(85.71) were reached for a cutoff value of>70.2 mg/L at day 4.
Cutoff values at day 5 and day 10 did not reach equally
reliable predictive values for positive and negative outcome
(►Table 1).
Fig. 2 Boxplot graphs of C-reactive protein (CrP) development in patients with successful wound closure (A) and those patients where no closure was
achieved (B).
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Thrombocyteswere lower innon-closedpatients at all time
points. Protein and albumin both showed mild decreases
during treatment; however, values tended to be higher in
non-closed patients. A summary of mean values, standard
deviation, effect size and p-value reached for all tested para-
meters can be found in ►Table 2.
Discussion
To consider the fact that open wounds can be very hetero-
geneous in size, locationandpresenceof infection, thewounds
were treated as assigned by randomization. To minimize the
diversity of wounds and to keep the groups comparable, we
tried to include patients with comparable wounds, according
to localizationandorigin (►SupplementaryAppendix Table 1,
available in online version only), so that there was no kind of
over- or under-representation of a particular type of wound.
The aim of the present study was to evaluate the systemic
effect of NPWT for the treatment of complicated wounds.
Based on the results of the present study, we cannot fully
support the hypothesis that NPWT would positively inﬂu-
ence signs of systemic infection. This ﬁnding is especially
interesting compared with previous studies, which docu-
mented fewer caseswith progressing systemic inﬂammation
under NPWT treatment compared with foam.12 This might
have been overestimated previously due to study design
(retrospective nature, lack of randomization). However,
in contrast to the retrospective reports12,14 only few patients
in our study showed a systemic inﬂammation at the begin-
ning or during therapy. It might, therefore, also be possible
that systemic effects of NPWTmight becomemore obvious in
patients that already exhibit more profound systemic signs
at initiation of therapy.
We were only able to detect minor effects of NPWT for all
tested parameters with exception of protein loss; therefore,
this parameter might be worth further investigation. There is
currently only one additional study available that investigated
protein losses under NPWT treatment in humans.15 The
authors recorded a median total protein loss of 25  17 g/d
in patients treated with NPWT for the management of open
abdomens and 8  5 g/d for soft tissue wounds. Unfortu-
nately, these authors did not correlate total protein losses in
wound exudates to systemic values.15 It is questionable, if the
observed systemic difference in total protein in our study is
really related to NPWT treatment, or rather to the fact that the
mean protein score at day 0 was lower in NPWT-treated
patients comparedwith the foam treated patients. It is, there-
fore, not certain if the observed lower total protein in NPWT
was really related to the therapy regimen or rather represents
an effect of uneven randomization between groups.
Our second hypothesis was that prolonged systemic signs
of inﬂammation would be present in patients where suc-
cessful closure was not supported. Wound healing is a
complex process of inﬂammation followed by proliferation
and tissue maturation.1,2 While inﬂammation plays a major
part in initiation of this cascade, it becomes detrimental if it
persists.16 There are three components representing the
cornerstones for successful healing: cells of the immune
system (e.g. polymorphonuclear leucocytes, monocytes,
macrophages, mast cells, T-cells), inﬂammatory pathways
(e.g. interleukin-1β, tumour necrosis factor) as well as the
coagulation system (e.g. thrombocytes, contact activation
pathway, tissue factor pathway).2,16 With regard to this
knowledge, we found some interesting trends: patients
with higher initial leucocyte, band neutrophil counts and
thrombocyte counts were more likely to achieve closure.
Leucocytes have an important role inwound healing: they
prevent spread of infection by bacterial decontamination
and initiate the healing response by secretion of mediators
important for ﬁbroblast recruitment.1,2,16,17 After activation
of the complement system, platelet degranulation and
ongoing bacterial degradation attract neutrophils to the
scene.18 The observed phenomenon of initially higher counts
of leucocytes in patients with successful closure might
indicate a better or faster immune response leading to a
positive effect on subsequent wound healing. Similar obser-
vations have been made in horses before,3 but not in dogs. In
ponies, leucocytes produce more inﬂammatory mediators,
resulting in improved local defence, faster cellular debride-
ment, and a faster transition to the repair phase, with more
wound contraction.3 Our results may indicate that delayed
and insufﬁcient leucocyte recruitment might be one of the
steps leading to progressing local infection and delayed
healing. However, further studies elucidating the principal
pathways and effects on healing in dogs would be needed to
verify this ﬁnding.
Table 2 Youden index J, associated criterion, sensitivity, speciﬁcity and signiﬁcance level for CrP differed by day
Day Youden index J Associated criterion
(CrP mg/dL)
Sensitivity Specificity Significance level of
p-value (area 0.5)
0 0.4667 <15.26 66.67 80.00 0.1692
1 0.2619 <4.4 33.33 92.86 0.8859
2 0.5333 >130.4 66.67 86.67 0.4216
3 0.6750 >99.1 80 87.5 0.1546
4 0.6571 >70.2 80 86.71 0.0002
5 0.7857 >45.1 100 78.57 >0.0001
10 0.6667 >55.8 66.67 100 0.054
Abbreviation: CrP, C-reactive protein.
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Besides inﬂammatory cell types, the coagulation cascade is
an integral part of the inﬂammatory phase.2While these cells
are mostly recognized due to their role in haemostasis, they
serve as an important source for over 300 different growth
factors including chemokines and cytokines (platelet derived
growth factor, transforming growth factor-β1 and β2, ﬁbro-
blast growth factor, epithelial growth factor etc.).19 Activated
thrombocytes modulate phagocytosis, production of neutro-
phil extracellular traps and oxidative burst in neutrophils,
thereby contributing to the host immune reaction.20 Further-
more, they modulate early events in wound healing including
neovascularization and recruitment of ﬁbroblasts.19,21 Finally,
platelets localize and adhere to sites of bacterial lesions.20
Many of their cytokines actually have direct antibacterial
effects andactivatedplatelets can directly bind and internalize
bacteria themselves.20,22 In the present study, thrombocyte
countsweredecreased inpatientswhodidnot achieve closure,
andalthoughwedidnot reachsufﬁcientpower to investigate if
this was signiﬁcant, a major effect was detected. Thrombocy-
topenia indicates recruitment towards the focus of infection
and has been documented in severe bacterial infections in
humans before.21 Our ﬁnding that patients with non-success-
ful closure exhibited lower systemic thrombocyte counts
might therefore indicate a more severe state of infection
combined with a depletion of thrombocytes. However, one
major limitation of this study is that we did not correlate
systemic and local levels of leucocytes or thrombocytes and
their mediators. Further studies seem warranted to further
elucidate this interesting connection. While the detected
changes in leucocyte and thrombocyte counts were only
trends, signiﬁcant effects were detected for CrP. Contrary to
inﬂammatory cells, the acute phase protein CrP is a product of
inﬂammation that does not exert any positive effect onwound
healing itself, but rather acts as a marker for the severity of
inﬂammation caused by infectious and non-infectious ori-
gin.23 C-reactive protein is one of the major acute phase
proteins in dogs.24–26 It is a pattern recognition molecule
that binds to pathogens (bacterial-membrane) and cells
undergoing death.23 It is mainly generated by the liver where
the production of positive acute phase proteins is increased,
while albumin synthesis is decreased by inteleukin-6 and
interleukin 1β.23 Besides the liver, small amounts can also
be secreted by activated monocytes and lymphocytes.23
Aggregated CrP efﬁciently activates the complement system
through direct interaction with the classic pathway, which
is triggered by activation of the C1-complex and enhances
phagocytosis, and thus represents an important part of the
ﬁrst line of defence in the host.23 One major advantage of
CrP is that it rises markedly and rapidly once infection is
present or after surgical trauma.24,27 Numerous authors
have advocated the inclusion of CrP in standard inﬂamma-
tory panels in dogs, as it reacts quicker and more pro-
foundly than leucocytes.25,27,28 As seen in previous studies
investigating pyometra or sepsis,26,27,29,30 we were able to
detect that CrP more reliably documented the failure to
control local infection and subsequent non-successful
wound closure compared with leucocytes. We also found
that it is not only the absolute value at the beginning of
therapy, but rather the development over time that made
the difference. Similar to Dabrowski and colleagues, who
investigated CrP as a marker for surgical site infections after
pyometra surgery in bitches31, we found that values esti-
mated at day 4 had the highest prognostic value. This is in
part due to the fact that CrP is increased by surgical trauma,
it will rise as fast as 6 hours after surgery and peak around
12 to 24 hours after completion.31,32 Therefore, monitoring
CrP at day 1 is of little value if taken alone; however, if taken
as a reference value for further development, it might
become useful. Based on the results of our study, laboratory
evaluations at day 1 and 4 after surgery seem most war-
ranted for monitoring of inﬂammation.
It is interesting that total protein and albuminvalues did not
differ markedly between patients with successful or non-suc-
cessful closure, even if they represent one of the factors known
to inﬂuence wound healing.2 This might be due to the fact that
these values will only be altered in severely ill patients, and are
thus not sensitive enough to mirror subtle changes in local
wound infections. There are several limitations to this study,
including sample size, differences in wounds (localization,
reason, size) and the lack to correlate systemic and local factors,
which should be addressed in future studies. Investigation of
wound exudate in dogs might be warranted, as it might
resemble a more accurate and less invasive source for monitor-
ing of local processes.
Conclusion
From the results of this study, we conclude that several
parameters seem interesting regarding further investigation
of their prognostic power in wound closure, including leu-
cocyte and thrombocyte count as well as total protein.
Among the tested parameters, CrP seems to be the most
valuable parameter regarding the prediction of successful
wound closure, with a cutoff value of 70.2 mg/L at day 4
reaching the highest sensitivity and speciﬁcity.
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